Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular Histone H4 is a core histone protein released into the extracellular space during cell death or tissue injury. It acts as a damage-associated molecular pattern (DAMP), triggering immune responses, cytotoxicity, and inflammation. It has been implicated in organ failure during sepsis and other critical illnesses, acting via membrane permeabilization, TLR/NLRP3 pathway activation, and Ca²⁺ influx. Neutralizing antibodies and polyanionic drugs are under investigation as therapeutic strategies.
Membrane permeabilization; TLR2/TLR4/NLRP3 pathway activation; Ca²⁺ influx
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Histone H4.